HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sonoda, S. Search for Related Content PubMed PubMed Citation Articles by Sonoda, S.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation

Serial intravascular ultrasound analysis from the sirius trial

Shinjo Sonoda, MD^*, Yoshihiro Morino, MD^*, Junya Ako, MD^*, Mitsuyasu Terashima, MD^*, Ali H. M. Hassan, MD^*, Heidi N. Bonneau, RN, MS, Martin B. Leon, MD, FACC, Jeffrey W. Moses, MD, FACC, Paul G. Yock, MD, FACC^*, Yasuhiro Honda, MD^*, Richard E. Kuntz, MD, MSc, Peter J. Fitzgerald, MD, PhD, FACC^*,* for the SIRIUS Investigators

^* Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, California, USA
Highlands Consulting Inc., San Jose, California, USA
Lenox Hill Hospital, New York, New York, USA
Brigham and Women's Hospital, Boston, Massachusetts, USA

Manuscript received November 4, 2003; revised manuscript received January 8, 2004, accepted January 27, 2004.

^* Reprint requests and correspondence: Dr. Peter J. Fitzgerald, Center for Research in Cardiovascular Interventions, Stanford University Medical Center, 300 Pasteur Drive, H3554, Stanford, California 94305-5637, USA.
ivus{at}crci.stanford.edu

OBJECTIVES: We assessed the predictive value of minimum stent area (MSA) for long-term patency of sirolimus-eluting stents (SES) implantation compared to bare metal stents (BMS).

BACKGROUND: Although MSA is a consistent predictor of in-stent restenosis, its predictive value in BMS is still limited because of biologic variability in the restenosis process.

METHODS: From the SIRolImUS (SIRIUS) trial, 122 cases (SES: 72; BMS: 50) with complete serial intravascular ultrasound (IVUS) (baseline and 8-month follow-up) were analyzed. Postprocedure MSA and follow-up minimum lumen area (MLA) were obtained. Based on previous physiologic studies, adequate stent patency at follow-up was defined as MLA >4 mm².

RESULTS: In both groups, a significant positive correlation was observed between baseline MSA and follow-up MLA (SES: p < 0.0001, BMS: p < 0.0001). However, SES showed higher correlation than BMS (0.8 vs. 0.65) with a higher regression coefficient (0.92 vs. 0.59). The sensitivity and specificity curves identified different optimal thresholds of MSA to predict adequate follow-up MLA: 5 mm² for SES and 6.5 mm² for BMS. The positive predictive values with these cutoff points were 90% and 56%, respectively.

CONCLUSIONS: In this SIRIUS IVUS substudy, SES reduced both biologic variability and restenosis, resulting in increased predictability of long-term stent patency with postprocedure MSA. In addition, SES had a considerably lower optimal MSA threshold compared to BMS.

Abbreviations and Acronyms   BMS = bare metal stents   IVUS = intravascular ultrasound   MLA = minimum lumen area   MSA = minimum stent area   SES = sirolimus-eluting stents

This article has been cited by other articles:

				E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo Drug-Eluting Stenting: The Case for Post-Dilation J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31. [Abstract] [Full Text] [PDF]

				G. S. Mintz What to Do About Late Incomplete Stent Apposition? Circulation, May 8, 2007; 115(18): 2379 - 2381. [Full Text] [PDF]

				D. Matsumoto, J. Shite, T. Shinke, H. Otake, Y. Tanino, D. Ogasawara, T. Sawada, O. L. Paredes, K.-i. Hirata, and M. Yokoyama Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur. Heart J., April 2, 2007; 28(8): 961 - 967. [Abstract] [Full Text] [PDF]

				B. J.G.L. de Smet and F. Zijlstra A look at drug eluting stents with optical coherence tomography Eur. Heart J., April 2, 2007; 28(8): 918 - 919. [Full Text] [PDF]

				D. E. Kandzari, M. B. Leon, J. J. Popma, P. J. Fitzgerald, C. O'Shaughnessy, M. W. Ball, M. Turco, R. J. Applegate, P. A. Gurbel, M. G. Midei, et al. Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease: A Randomized Controlled Trial J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2440 - 2447. [Abstract] [Full Text] [PDF]

				G. S. Mintz and N. J. Weissman Intravascular Ultrasound in the Drug-Eluting Stent Era J. Am. Coll. Cardiol., August 1, 2006; 48(3): 421 - 429. [Abstract] [Full Text] [PDF]

				M.-K. Hong, G. S. Mintz, C. W. Lee, D.-W. Park, B.-R. Choi, K.-H. Park, Y.-H. Kim, S.-S. Cheong, J.-K. Song, J.-J. Kim, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation Eur. Heart J., June 1, 2006; 27(11): 1305 - 1310. [Abstract] [Full Text] [PDF]

				R. A. Costa, G. S. Mintz, S. G. Carlier, A. J. Lansky, I. Moussa, K. Fujii, H. Takebayashi, T. Yasuda, J. R. Costa Jr, Y. Tsuchiya, et al. Bifurcation Coronary Lesions Treated With the "Crush" Technique: An Intravascular Ultrasound Analysis J. Am. Coll. Cardiol., August 16, 2005; 46(4): 599 - 605. [Abstract] [Full Text] [PDF]

				L. Mauri, E. J. Orav, and R. E. Kuntz Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison Circulation, June 28, 2005; 111(25): 3435 - 3442. [Abstract] [Full Text] [PDF]

				K. Fujii, S. G. Carlier, G. S. Mintz, Y.-m. Yang, I. Moussa, G. Weisz, G. Dangas, R. Mehran, A. J. Lansky, E. M. Kreps, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study J. Am. Coll. Cardiol., April 5, 2005; 45(7): 995 - 998. [Abstract] [Full Text] [PDF]